Composition and methods for sensitive molecular analysis

Abstract

A method for ascertaining the presence of target-bound microbubbles in the context of ultrasound molecular imaging is taught. This method, referred to herein as dynamic scaling ultrasound molecular imaging, relies upon the time-varying behavior contrast agents within a region expressing a molecular imaging target and that within a reference region. Ultrasound contrast agent compositions that enable use of the method are also taught. The invention is useful for the use of ultrasound molecular imaging in diagnosing disease and monitoring treatment.

What is claimed is: 
     
         1 . A method of detecting a disease in a subject comprising imaging a field of view within the subject for between 1-10 minutes and storing the series of images in a readable computer medium; performing a quantifying method for quantifying magnitude of a contrast signal within a region of interest (ROI) on the obtained image time series; presenting the scaled image sequence or the scaled signal plot such as a time-intensity curve to a user; and determining a disease based on the rates of change of the scaled signals, wherein the quantifying method comprises administering to a target tissue of a subject a targeted contrast agent to image presence of one or more targeted molecular markers of disease; selecting a reference region representative of the amount of contrast agent circulating within the blood pool in a dynamic scaling, time-varying manner; imaging said target tissue including the selected reference region; determining the magnitude quantitatively of an area of disease by said dynamic scaling, time-varying manner procedure wherein said targeted contrast agent is configured to be bound to said one or more molecular markers of disease expressed within the diseased region. 
     
     
         2 . The method of  claim 1 , wherein said dynamic scaling, time-varying manner procedure comprises
 a. providing a time series of images depicting a single field of view,   b. selecting one or more regions of interest and one or more corresponding reference regions,   c. forming a reference-scaled image, and/or a reference-scaled signal magnitude in which the region of interest and reference region are obtained at the same instant in the time series,   d. performing the scaling operation of (c) on two or more images in the time series to determine the time-intensity relationship of the reference-scaled signal magnitude quantitatively; wherein the reference-scaled signal increases in the diseased region and decreases in the non-diseased region.   
     
     
         3 . The method of  claim 2 , wherein the reference-scaled contrast signal magnitude is computed within one or more target regions at several timepoints between peak signal and clearance of the reference region. 
     
     
         4 . The method of  claim 2 , wherein the reference-scaled contrast signal magnitude is computed at peak signal and at a subsequent time point of interest, and the average slope between the two points is computed. 
     
     
         5 . The method of  claim 1 , wherein the field of view comprises a heart, a kidney, a liver, a breast, a tumor, a prostate, or the like. 
     
     
         6 . The method of  claim 5 , wherein the field of view comprises a heart. 
     
     
         7 . The method of  claim 6 , wherein a LV chamber is a reference region and myocardium is a target region. 
     
     
         8 . The method of  claim 4 , wherein a dynamic scaling procedure is performed on the linearized contrast signal. 
     
     
         9 . A dynamic scaling, time-varying manner procedure used to determine the levels of the interested molecular marker in the target tissue comprises
 a. capturing a series of images of a target tissue over time,   b. choosing a region of interest within the images that has targeted contrast agent signals,   c. choosing a reference region of interest within the images that doesn't have targeted contrast agent signals but has circulating contrast agent signals,   d. using the signal intensities of the reference region to scale the signal magnitudes from the targeted region at each time points;   e. creating reference-scaled images or magnitudes of the target tissue in the different time points, and   f. using the reference-scaled images or magnitudes to determine the levels of the interested molecular marker in the target tissue.   
     
     
         10 . The procedure of  claim 9 , wherein the procedure is performed in units of linearized acoustic power. 
     
     
         11 . The procedure of  claim 9 , wherein the procedure is performed in units of linearized acoustic amplitude. 
     
     
         12 . The procedure of  claim 9 , further comprising color coding of the dynamically scaled images or the rate images derived from the rates of change of the dynamically scaled images. 
     
     
         13 . The procedure of  claim 9 , further comprising smoothing by low-pass filtering of the dynamically scaled images. 
     
     
         14 . The procedure of  claim 9 , further comprising nonlinear compression of the dynamically scaled images. 
     
     
         15 . The procedure of  claim 9 , wherein the reference scaled signal magnitude is computed within one or more target regions at several timepoints between peak signal and clearance of the reference region. 
     
     
         16 . The procedure of  claim 9 , wherein the reference scaled signal magnitude is computed at peak signal and at a subsequent time point of interest, and the average slope between the two points is computed. 
     
     
         17 . The method of  claim 1 , wherein said targeted contrast agent is P-selectin targeted microbubbles. 
     
     
         18 . The method of  claim 1 , wherein said one or more targeted molecular markers comprise CD62.